logo
  

UroGen Pharma Ltd. Q2 Loss Rises

UroGen Pharma Ltd. (URGN) released Loss for its second quarter that increased from the same period last year

The company's earnings came in at -$26.69 million, or -$1.18 per share. This compares with -$26.22 million, or -$1.17 per share, in last year's second quarter.

The company's revenue for the quarter rose 27.4% to $16.60 million from $13.03 million last year.

UroGen Pharma Ltd. earnings at a glance (GAAP) :

-Earnings (Q2): -$26.69 Mln. vs. -$26.22 Mln. last year.
-EPS (Q2): -$1.18 vs. -$1.17 last year.
-Revenue (Q2): $16.60 Mln vs. $13.03 Mln last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT